A study of treatment of autonomic nervous system-related disorders with MSC-CM
- Conditions
- Autonomic Nervous System-related DisordersD001342
- Registration Number
- JPRN-jRCT1051230175
- Lead Sponsor
- agamine Yukiko
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
1. Those for whom satisfactory treatment effects were not observed with standard therapy.
2. Individuals who do not wish to undergo treatment with drugs commonly used in standard therapy due to concerns about side effects, and have been deemed suitable for treatment with conditioned medium by a physician.
The patient selection criteria are as follows:
Patients meeting the following criteria will be considered eligible:
Individuals aged 18 and above.
Individuals with normal decision-making capacity.
Individuals who have been provided with the informed consent document regarding this treatment, received sufficient explanation, and can provide voluntary written consent.
Individuals for whom the attending physician has recognized the necessity of treatment.
Individuals meeting any of the following conditions will be excluded from the study:
1. Users of narcotics or stimulants.
2. Individuals deemed inappropriate by the attending physician.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Assessment of Self-Reported Symptoms Corresponding to Types of Autonomic Dysfunction in Dysautonomia
- Secondary Outcome Measures
Name Time Method